Our Videos

September 22, 11

NEWS / Florida Manufacturer Agrees to Cease Production of Skin Products to Resolve Numerous FDCA Violations

Justice Department Takes Action On Behalf of FDA

WASHINGTON Ė The Justice Department, at the request of the Food and Drug Administration (FDA), today filed a complaint and a consent decree in the U.S. District Court for the Middle District of Florida against Hill Dermaceuticals Inc., Hill Labs Inc., Jerry S. Roth and Rosario G. Ramirez. The complaint and consent decree are being filed today to in accordance with an agreement with the defendants resolving numerous violations of the Food, Drug and Cosmetic Act.

The defendants manufacture and distribute prescription drug products, including scalp oil, body oil, eardrops, skin cream and medicated shampoo used in the treatment of dermatitis, otiti, and other skin conditions. Hill Labs manufactures drug products and sells them to Hill Dermaceuticals, which markets and distributes them. Roth is the president of both corporations, and Ramirez is quality assurance manager.

The governmentís action today is the culmination of a series of inspections by the FDA of Hillís Sanford, Fla., facility at various times from 2004 to 2010. In the course of these inspections, the FDA documented numerous deficiencies in Hillís current good manufacturing practices (CGMPs). CGMPs provide for systems that assure proper design monitoring and control of manufacturing processes and facilities. This includes establishing strong quality management systems, obtaining appropriate raw quality materials, establishing robust operating procedures, detecting and investigating product quality deviations and maintaining reliable testing laboratories. This formal system of controls not only helps to prevent instances of contamination, mix-ups, deviations, failures and errors, but ensures that drug products, such as those produced by Hill, meet their quality standards. Hillís CGMP violations concerned various aspects of their manufacturing processes, their testing methods, and their quality control procedures, in addition to their facilities and equipment.

In addition to these CGMP violations, the defendants submitted falsified data in support of at least two new drug applications. The complaint alleges that Hillís wrongful acts raise significant questions regarding reliability of any data that originated at Hillís Sanford facility.

Under the consent decree, the defendants cannot manufacture or distribute their products until an expert certifies that defendants are in compliance with the law. In addition, the defendants are also required to retain an expert to review and correct the data integrity and reliability problems that the FDA found.

ďWhen companies report false data to the FDA and fail to meet important manufacturing standards, they undermine the accountability process Congress put in place to protect public health,Ē said Tony West, Assistant Attorney General for the Justice Departmentís Civil Division. ďTodayís consent decree will ensure that Hill engages the experts, processes and procedures necessary for sustained compliance and safe products.Ē

The resolution of this matter was handled by Trial Attorney Drake Cutini of the Justice Departmentís Consumer Protection Branch and Michael Helbing, Assistant Chief Counsel, Food and Drug Administration.


Tags: document, corporation,


AnnaMaria Realbuto
Thank you for all your assistance and efficiency...
Read More »
Kateryna Melnychenko
Thanks a lot Anton!...
Read More »
Rani Payne
Thank you so much! Iím sure I will be in touch again with something else that will need to be apost...
Read More »
Serge Bauer Law
Thank you again for your help with this case!...
Read More »


How long did it take to write the Declaration of Independence?
Read More »
Are there circumstances in which the directors or officers of a company can be made personally liable in respect of its insolvency?
Read More »
Fair Credit Reporting Act . What is it?
Read More »
Why are documents notarized?
Read More »


September 19, 23
OK mom at risk of losing health insurance over daughterís birth certificate
Read More »
September 15, 23
Kansas prohibits gender changes on birth certificates
Read More »
September 13, 23
Death certificate issued for actor Paul Reubens, best known for playing Pee-wee Herman
Read More »
September 11, 23
Connecticut Assembly passes bill legalizing remote online notarization
Read More »